Strategy Abandons ‘Never Sell’ Bitcoin Policy, Signaling Potential BTC Exit

Strategy is making headlines by abandoning its long-standing “never sell” Bitcoin policy, placing 818,334 BTC—representing nearly 4% of the total supply—into play as an actively managed treasury asset. During Tuesday’s earnings call, CEO Phong Le confirmed that the company will now consider selling BTC to acquire dollars or retire debt, provided the transaction is accretive to Bitcoin per share. This marks a direct reversal of the core philosophy that Michael Saylor built the Strategy brand around.

“We will sell Bitcoin when it is advantageous to the company.” – @Strategy-CEO @PhongLe https://t.co/KFJBOql40V pic.twitter.com/yKHeF2Bvuw

— Tristan – Blocktrainer.de (@tristanblcktrnr) May 5, 2026

The position was acquired for $61.81 billion at an average cost of $75,500 per coin. A $12.5 billion net loss in Q1 2026, driven by the decline in BTC price at the start of the year, created the financial pressure that forced this pivot. MSTR shares jumped 3% in after-hours trading following the announcement.

Will Strategy dump its entire stack? It almost certainly will not. However, the shift from selling when people were asked to sell their kidneys to actively managing sales is not a seamless transition.

Sell a kidney if you must, but keep the Bitcoin.

— Michael Saylor (@saylor) February 28, 2025

Discover: Bitcoin price analysis – key support levels and what breaks them

What Happens to Bitcoin If Strategy Starts Selling?

Strategy’s 818,334 BTC is worth $61.8 billion at the average acquisition cost, but at the current spot value of $81,500, the position is valued at $66.8 billion. This volume is too large for a single order book to absorb cleanly.

Strategy’s previous purchases of $500 million–$1 billion in BTC have reliably moved spot prices upward by 2%–4% in the sessions following disclosure. The reverse dynamic of a coordinated sell program would face thinner liquidity on the ask side, particularly below the $75,000–$78,000 support band, where institutional bids concentrate.

Strategy Bitcoin Holdings, BitcoinTreasuries

Any meaningful disposal would almost certainly route through OTC desks rather than exchange order books. This limits slippage but does not eliminate price impact. A block sale of 5,000–10,000 BTC would represent one of the largest single institutional transactions in recent cycle history and would carry significant signal weight regardless of the execution venue.

Le’s stated condition of selling only when it is accretive to Bitcoin per share creates a governor on the program. However, market liquidity in the $70,000–$74,000 band is thin. If BTC breaks below the company’s average cost basis, the calculus around debt servicing versus holding shifts materially.

Forget the News, You Can Buy Bitcoin Hyper and Still Keep Your Kidney

Strategy’s current news is alarming for retail Bitcoin holders. Investors are seeking asymmetrical upside while BTC remains stuck under $100K, looking for solutions that enhance Bitcoin security by fixing its flaws without requiring the sale of a kidney to buy in.

Bitcoin Hyper ($HYPER) is a project drawing significant attention. Positioned as the first-ever Bitcoin Layer 2 with Solana Virtual Machine (SVM) integration, it aims to address Bitcoin’s three core limitations simultaneously: slow transactions, high fees, and limited programmability.

In short, Hyper delivers sub-second finality and low-cost smart contract execution while inheriting Bitcoin’s security model.

The presale has raised more than $32.5 million at a current token price of $0.0136, with 36% APY staking available for early participants. It remains affordable, and at this raised level, meaningful institutional and retail appetite is already present, yet the price remains early-stage by any measure. Keep your kidneys and get Hyper.

Research Bitcoin Hyper before the presale concludes.

The post Bitcoin News: Saylor “Sell a Kidney” Call is Now a BTC Exit? appeared first on Cryptonews.